Agoracom Blog Home

Posts Tagged ‘CSE’

« Older Entries
Newer Entries »

#Edtech Boom Boosted by Experiences in Lockdown – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 1:43 PM on Monday, May 25th, 2020

SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. betterU / Ottolearn launch FREE COVID-19 mobile resource toolkit to fight the global crisis – Click here for more information.

Edtech Boom Boosted by Experiences in Lockdown

  • Coronavirus lockdown opens new paths for online education
  • The edtech field may see its growth accelerating even faster because of pandemic
  • The world of education and worker retraining has been upended by the coronavirus, with many changes that could have long-lasting impacts

By: Bruce Rule

Teacher Kai Frazier had a hard time persuading venture capital investors to consider her online education startup, which provides virtual-reality tours of museums and historic sites for children. Then the deadly coronavirus caused societies to shut down worldwide.

“VCs thought that this was only for poor kids who couldn’t afford to go to museums,” Frazier told Karma. “COVID-19 took that argument out” and led potential investors to reconsider Kai XR, she said. Now, Frazier is in the midst of a funding round that may net between $500,000 and $1 million.

With almost 1.2 billion children locked out of schools and millions of adults out of work around the globe, the deadly coronavirus pandemic is forcing the world to re-examine how best to educate and retrain people. That may spur even faster growth of online education, a field that was already expected to surge to $319 billion by 2025 from $188 billion last year.

“COVID-19 is a terrible thing, but what it also did was break down structures that weren’t serving a lot of people,” Frazier said. “Online education may quickly become the classroom experience.”

Her company produces virtual reality tours — like this one of the Obama portraits — that will be viewed online for a monthly subscription fee on a platform that launched last month. The company has seen a 200% increase in people signing up for a free demonstration because of the pandemic.

With VR tours, a child can have a wide range of experiences — from touring a Negro League baseball museum to seeing how a windmill works — that might not otherwise be available because of cost or distance, Frazier said. Online can provide a “diverse education.”

Investors certainly are betting so. A record $18.7 billion was invested in edtech companies worldwide last year, according to research firm Metaari. The pandemic doesn’t seem to have killed enthusiasm for the field. In March, online education company Yuanfudao of China raised $1 billion in a finance round led by Tencent Holdings and private equity firm Hillhouse Capital Group.

According to education research firm HolonIQ, a lot of that growth will eventually be in emerging markets in India, Southeast Asia, Latin America and Africa, “where multi-billion dollar funds are being set up to deploy capital into education and other ESG and impact sectors.”
   
Worker retraining also has become a hot topic, with a White House advisory panel last week saying new pathways are needed for the unemployed to upgrade their skills and learn new ones so they can find jobs in fields that are expected to rebound first.

Guild Education is responding to that need. The edtech company was founded in 2015 to help employers including Chipotle, Disney and Walmart create education programs for workers by connecting companies with higher-ed programs at nonprofit universities.

Earlier this month, Guild launched the Next Chapter platform, which enables employers to
provide laid-off workers with access to reskilling programs and hands-on coaching to help them qualify for new positions in areas where demand will increase as the economy reopens.

“Next Chapter was created to help workers make the leap to higher wage” positions, Rachel Carlson, Guild’s CEO, said in an email to Karma.

Investors are also jumping into the field of worker training. Online training platform GO1.com announced this week it raised $40 million in Series C funding.
 
“What has been made clear through this pandemic is the importance of disseminating knowledge across borders, companies, and all parts of society,” The World Economic Forum said in a report last month. “If online learning technology can play a role here, it is incumbent upon all of us to explore its full potential.”

Source: https://karmaimpact.com/edtech-boom-boosted-by-experiences-in-lockdown/

Tags: , , , , ,
Posted in betterU Education Corp | Comments Off on #Edtech Boom Boosted by Experiences in Lockdown – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Mota Ventures $MOTA.ca Signs LOI to Acquire Ecommerce Platform Leader Unified Funding, LLC, Which Generated $96.5m in Consumer Transactions in 2019 $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 1:02 PM on Saturday, May 23rd, 2020
  • Unified has a database of over one million customers and facilitated over $375,000,000(Cdn) in consumer transactions
  • Unified’s platform generates revenue from licensing, marketing and product fulfillment fees, supporting brands in skin care, essential oils, men’s health, weight management and CBD

VANCOUVER, BC / ACCESSWIRE / May 23, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC PINK:PEMTF) (the “Company”) is excited to announce it has entered into a Letter of Intent (the “LOI”) dated May 21, 2020, to evaluate the acquisition (the “Proposed Transaction”) of Unified Funding, LLC (“Unified”). Since inception in 2015, Unified has generated a database of over one million customers and has facilitated over Cdn$375,000,000 in consumer transactions. Powered by its proprietary technology platform, Unified has created an eCommerce ecosystem to scale its brands and achieve profitability targets through data analysis, strategic customer acquisition and supply chain management. Founded by partners with more than a decade of eCommerce and technology experience, Unified has rapidly grown into a formidable business focused on aggressive expansion in the natural health products market. Unified’s diverse platform generates revenue from; licensing, marketing and product fulfillment fees supporting brands in skin care, essential oils, men’s health, weight management and CBD including MOTA’s recently audited Nature’s Exclusive brand. Figures presented in this news release were translated from US dollars into Canadian dollars using the Bank of Canada closing exchange rate on May 22, 2020 of US$1.00:Cdn$1.3892.

“A transaction with Unified is another step forward in our expansion as a global eCommerce business. This is the platform and personnel necessary for MOTA to launch and grow brands, such as Nature’s Exclusive, which we acquired from Unified in January of 2020. Unified has developed a comprehensive eCommerce platform that is ideally suited for the natural health products sector. Integration of their platform and the personnel to run it will allow us to rapidly deploy new products and expand into new natural health product segments and markets,” stated Ryan Hoggan, CEO of the Company.

Beyond Unified’s comprehensive eCommerce technology platform, their services assist brands with launching and scaling customer acquisition strategies. Through a worldwide network of media partners, Unified is able to closely monitor market trends to guide product innovation and marketing strategies that yield profitable results.

“We have created a very comprehensive eCommerce platform with a team of data analysis, strategic customer acquisition and supply chain management experts that has been proven effective for rapid expansion of natural health brands. We are hopeful that a transaction with Mota will allow our group to use our skills to expand into additional international markets, create new natural health brands and reach more consumers. Mota’s access to capital markets to raise growth capital to invest in customer acquisition will give us a distinct advantage to quickly scale, diversify and expand into new high growth product offerings,” stated Kevin Keranen, Chairman of Unified.

Readers are cautioned that the LOI entered into with Unified does not set forth the terms of the Proposed Transaction, nor have such terms been finalized. Completion of the Proposed Transaction is subject to a number of conditions, including, not limited to, completion of due diligence, negotiation of definitive documentation, and the receipt of any required regulatory approvals. The Proposed Transaction cannot be completed until these conditions are satisfied and there can be no assurance that the Proposed Transaction will be completed at all.

The Proposed Transaction is not expected to constitute a fundamental change for the Company, nor is it expected to result in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. The Company will provide further information regarding its review of Unified, and the Proposed Transaction, as that information becomes available.

About Mota Ventures Corp.

Mota is an established eCommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its Nature’s Exclusive brands. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

About Unified Funding, LLC

Founded in 2015 by partners with more than a decade of eCommerce and technology experience, Unified has rapidly grown into a formidable organization focused on aggressive expansion in the natural health products market. Powered by its proprietary technology platform, the company has created an eCommerce ecosystem to scale its brands and achieve profitability targets through data analysis, strategic customer acquisition and supply chain management. For more information about Unified, please visit https://www.unifiedbrandlab.com/.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President & CEO at +604.423.4733 or by email at [email protected]or www.motaventuresco.com

Tags: , , , , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Mota Ventures $MOTA.ca Signs LOI to Acquire Ecommerce Platform Leader Unified Funding, LLC, Which Generated $96.5m in Consumer Transactions in 2019 $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Else Nutrition $BABY.ca Provides Corporate Update – Product Launch In U.S. Expected In Q3 $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 10:41 AM on Friday, May 22nd, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Engagement with Covet PR ahead of planned product launch in the U.S.; Covet specializes in alternative foods promotion with clients such as Beyond Meat, Banza, Kashi, Once Upon a Farm, and many others
  • Positive social campaign testing results, reached over 320,000 potential customers in the U.S.
  • Partnership with “Mom’s Meet”, a community of approximately 100,000 U.S. moms dedicated to exploring new children products
  • Product launch in the U.S. expected in late July or early August 2020 (4-8 week delay from original pre-July launch date due to Covid 19)
  • Toddler Nutrition product sampling campaign planned to launch on June 15, 2020

VANCOUVER, BC / May 22, 2020 / ELSE NUTRITION HOLDINGS INC. (TSX-V:BABY) (OTCQB:BABYF) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide the following corporate update.

Marketing for Upcoming Product Launch

Else is pleased to announce that it has engaged Covet PR, a national U.S.-based public relations firm devoted to food, beverage, beauty and lifestyle brands. Covet will) support the launch of Else products into the U.S. marketplace in Q3-2020. Covet’s client roster includes impressive, disruptive and leading wellness brands, such as: Beyond Meat, Banza, Kashi, Once Upon a Farm, and many other better-for-you consumer product companies.

“As experts in the plant-based nutrition space, we are thrilled to be partnering with Else Nutrition for their U.S. launch,” says Sara Brooks, Founder, and CEO of Covet PR. “At Covet PR, we are passionate about companies that are truly innovating, making this world a healthier and happier place. Furthermore, as a mom of two young children, I am equally as excited about having a better, complete nutrition solution I can depend on, and I look forward to sharing this brand with consumers nationwide.”

During the month of April, Else executed its first paid test campaigns on social media platforms, showing highly promising results and customer engagement. The brand was exposed to over 320,000 potential U.S. customers, with more than double the industry average clickthrough rate. The clickthrough rate is a widely accepted industry standard indicator of high customer interest in the brand. Insights gleaned from this campaign will be integrated into a sampling campaign planned to launch on June 15th 2020, when customers will be able to order Else Toddler Nutrition samples.

The Company has also partnered with Mom’s Meet, a dedicated community of approximately 100,000 U.S. moms exploring new consumer products for their children. The program will raise brand awareness among this group via digital communications, and will drive sampling for Else Plant-Based Toddler Nutrition.

Product Launch Date

Management is pleased to announce that the impact of the COVID-19 pandemic, on Company’s business was minimal, causing an approximate 2 month delay in product launch which is currently scheduled for late July or early August 2020. Else also expects to finalize its agreement with a leading U.S.-based organic baby formula manufacturer for the production of its plant-based toddler nutrition product in June of 2020.

About Else Nutrition Holdings Inc.

Else Nutrition GH ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, 100% plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition won the “2017 Best Health and Diet Solutions’ award at the Global Food Innovation Summit in Milan. The holding company, ELSE Nutrition Holdings Inc, is a publicly-traded company, listed as TSX-V: BABY, as part of the TSX Venture Exchange and as OTCQB: BABYF as part of the NY OTC QB Exchange. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPHGAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)52-447-9931

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that, to the extent they are not recitations of historical fact, constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “plan”, “hope to”, “intend” or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements with respect to: the Company’s commercialization of its products and expected timing, expected go-to-market strategy (including marketing, proposed markets, sales, customer growth and market position), and industry conditions including any impact of Covid-19. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the successful completion of Else’s proposed scale-up for its products, restrictions due to Covid-19 will not result in additional unplanned delays, and such statements are intended to apply only to the infant formula market for ages 12 months and above, and having all necessary regulatory approval as required by each target market. Numerous risks and uncertainties could cause the Company’s actual results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to: consumer demand for the Company’s products, whether the Company’s current and future products achieve commercialization, uncertainty regarding material changes in laws and regulations, retention of key personnel, the Company’s ability to expand into global markets and competitive developments, and the impact of Covid-19 on the planned business operations. The foregoing list of factors is not exhaustive, and other risks and uncertainties not presently known, or believed to be material, to management Additional information and other factors that could affect the operations or financial results of the Company are set out in the Company’s Filing Statement dated May 14, 2019 under the heading “Risk Factors” and may be accessed through the SEDAR website (www.sedar.com). Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law

Tags: , , , , ,
Posted in Else Nutrition Holdings Inc., Featured | Comments Off on Else Nutrition $BABY.ca Provides Corporate Update – Product Launch In U.S. Expected In Q3 $MAT $KMB $BMY $ABT $WYE

Serial Entreprenuer and Former Aurora Cannabis $ACB CEO, Terry Booth, Joins Eyecarrot $EYC.ca as Executive Chairman $EYPT $KALA

Posted by AGORACOM-JC at 3:04 PM on Thursday, May 21st, 2020
http://www.smallcapepicenter.com/eyc%20square.png
  • Announced the appointment Aurora Cannabis (TSX-ACB) Founder and former CEO, Mr. Terry Booth, to the Company as Executive Chairman.
  • Mr. Booth was one of the 2 original founders of Aurora Cannabis Inc. In 2013, he personally provided over $3.0 million in start-up capital to the building of a new from the ground up high quality purpose-built medical cannabis production facility in Mountain View County.
  • Appointed CEO in December 2014, he has skillfully raised Aurora from its infancy into one of the world’s largest and fastest growing cannabis companies, valued at $18B at its peak

Toronto, New York -  May 21st, 2020 – Eyecarrot Innovations Corp (TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR), is pleased to announce the appointment Aurora Cannabis (TSX-ACB) Founder and former CEO, Mr. Terry Booth, to the Company as Executive Chairman. Mr. Booth was one of the 2 original founders of Aurora Cannabis Inc. In 2013, he personally provided over $3.0 million in start-up capital to the building of a new from the ground up high quality purpose-built medical cannabis production facility in Mountain View County. This facility was the first in the world to be certified as 100% EU GMP compliant for the production of Medical Cannabis. Appointed CEO in December 2014, he has skillfully raised Aurora from its infancy into one of the world’s largest and fastest growing cannabis companies, valued at $18B at its peak, with a focus on providing high-quality medical and adult usage cannabis and inspiring better days for medical and recreational consumers around the world.

A visionary and passionate leader, Terry has a deep knowledge of highly regulated environments. He was instrumental in Aurora receiving its initial licensing and approval from Health Canada to produce medical cannabis, as well as building the Company’s state of the art cultivation facility Aurora Sky. With this strong entrepreneurial vision running through the entire company, Terry has overseen the company’s organic growth as well as its expansion through acquisitions of companies, all of which were successfully integrated into the parent company.

“I am beyond excited to be a part of a new technology platform that will focus on improving vision globally. In particular, improving youth vision through this revolutionary technology that has not only been proven but is being used by world class athletes to improve their binocular vision, balance, and strength. Our product will set the standard in this nascent industry on a global basis,” commented Terry Booth, Executive Chairman

Uniquely skilled at seizing M&A opportunities, (over 30 transactions and acquisitions in the last 5 years) Terry also has more than 25 years of experience in creating, growing and leading companies in highly regulated industries. Terry currently sits on the board of Aurora Cannabis, Quinsam Capital, and Psyched Wellness and has sat on the board of other organizations, including Radient Technologies and Alcanna (formerly Liquor Stores N.A.). Terry has also served as President/CEO of Superior Safety Codes Inc, which was recognized as one of Canada’s top 50 fastest-growing companies. Terry joins Eyecarrot with an established track-record of transformational leadership and a purpose to impact Global Health and Education.

“We are absolutely thrilled to add the expertise and experience of a member of Terry’s caliber, and the team at Eyecarrot firmly believes that this will set our path moving forward. With his proven track record in building and growing businesses in technologically and medically innovative fields, Terry brings an unsurpassed wealth of knowledge to our dedicated and motivated team. He has the unique ability to move mountains when it comes to policy at the national and international level, as well as an incredible track record in capital markets. We’re excitedly looking forward to working together to accomplish our goals, bring value to our investors, and ultimately improve human performance,” commented Eyecarrot Founder and CEO Adam Cegielski.

In connection with these corporate changes, the Company would also like to announce it as arranged a non-brokered private placement to raise up to $1 million through the issuance of up to 7,843,137 units at a price of $0.1275 per unit, subject to the approval of the TSX Venture Exchange.

Each unit will comprise one common share and one share purchase warrant. Each warrant will entitle the holder to acquire a further common share at a price of $0.25 per share for a period of 24 months, subject to an acceleration clause whereby if the closing price of the Company’s shares is equal to or greater than $0.50 per share for a period of five consecutive trading days (at any time following the expiry of the four month resale restriction period), the Company, may, by notice to the warrant holder, reduce the remaining exercise period of the warrants to not less than 30 days from the date of such notice. The proceeds of the placement will be utilized for the further development of the Company’s products and for general working capital purposes. Mr. Booth is expected to subscribe for up to 1,960,785 units of the financing.

The Company also announces the grant of an aggregate of 2,500,000 stock options at an exercise price of $0.17 per share for a period of five years to directors, officers, employees and consultants, of which 500,000 stock options will be granted to Mr. Booth.

Dr. John Flanagan has resigned from the Board of Directors of the company to make room for Mr. Terry Booth, and will now be the first member of the company’s Scientific Advisory Board.

Please visit https://www.eyecarrot.com/investors/ for additional information on the Company.

About Eyecarrot Innovations Corp (EYC)

Eyecarrot is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

On behalf of the Board of Directors

Adam Cegielski

President | CEO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.eyecarrot.com/investors/

Forward looking information

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , ,
Posted in Eyecarrot Innovations Corp | Comments Off on Serial Entreprenuer and Former Aurora Cannabis $ACB CEO, Terry Booth, Joins Eyecarrot $EYC.ca as Executive Chairman $EYPT $KALA

Mota Ventures $MOTA.ca Talks Strategy on Mushrooms and CBD $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 9:30 AM on Thursday, May 21st, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

Results of the 2019 calendar year audit of Nature’s Exclusive:

  • Revenue of Cdn$29,034,000
  • Net income of $3,505,000
  • Achieved a margin of over 12%

VANCOUVER, BC / ACCESSWIRE / May 21, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ1)(OTC PINK:PEMTF) (the “Company“) would like to thank all shareholders and investors for attending yesterday’s investor call. The main items addressed on the call were the completion of 2019 audit of the Nature’s Exclusive brand and the expansion of business in the natural health products sector through the proposed acquisition of Verrian.

The 2019 financial results for the Nature’s Exclusive brand is a strong indicator of the power of the Company’s eCommerce business model. This growth continued into 2020. For the months January through April 2020, the Company has generated revenue of Cdn$13,968,000 with related expenses of Cdn$13,514,000. Revenue has increased 188% for this time period over the same period during 2019. The Company’s customer acquisition and subscription retention strategies are yielding benefits through the year and into May where the Nature’s Exclusive brand has acquired over 17,613 customers from May 1st through May 18th. With over 60% of these customers electing into a subscription, the Company expects reduced costs in the following months, as customer acquisition expense is a one-time cost per customer.

As a leading business in the natural health products sector, we’ve been aggressively looking to expand our offering into growing segments of the market. Through this process, we identified psychedelic medicine as a unique opportunity, due to the overwhelming momentum of the sector and the incredible health benefits that can be obtained through derivative products.

The Company has come to terms to acquire Verrian, a leading company in the psychedelic medicine sector. Verrian owns and operates an established 110,000 square-foot pharmaceutical manufacturing facility in Germany that holds EU-GMP, ISO 14001, and narcotics manufacturing licenses. The facility and equipment of Verrian have been independently appraised at Cdn$10,600,000 and include an analytical laboratory and full pharmaceutical manufacturing suite.

Beyond the importance of this manufacturing asset, Verrian’s product commercialization process is already underway. The business has invested over Cdn$2,000,000 in clinical trials with two studies that are ongoing. These studies combined with our manufacturing abilities will uniquely prepare us to go-to-market once approval is granted.

Verrian’s product development pipeline is incredibly strong with two products named PSI Gen and PSI Gen+, which are both natural psilocybin extracts from organic mushrooms combined with metabolism-enhancing natural herbs. While there are many benefits patients may realize from utilizing psychedelic medicine, Verrian is focusing on opioid addiction reduction. This is an important mission as a company as it is estimated that over 13 million people in the world take opioids. For those individuals who have suffered a loss due to one’s addiction to a medically prescribed pharmaceutical, this holistic approach provided by Verrian and Mota is even more meaningful. In addition to treatments for opioids, new studies have demonstrated successful psilocybin treatments for both alcoholism and depression, substantially increasing the market size of potential patients. According to Marketdata, the United States market for alcohol and drug addiction rehab will be worth $42,000,000,000 in 2020, with over 15,000 private treatment facilities and growing.

“Our acquisition of Verrian is another step forward in executing our vision to use our powerful eCommerce platform for new and innovative natural health products. While we continue to grow and expand our CBD business units, we will also be ready to fully commercialize the technology created by Verrian. I look forward to working with Verrian’s incredibly talented team of clinical researchers and addiction medicine professionals within our existing ecosystem as it will uniquely position us as a leader in psychedelic medicine,” stated Ryan Hoggan, CEO of the Company.

Completion of the acquisition of Verrian remains subject to a number of conditions, including completion of due diligence, receipt of any required regulatory approvals and the negotiation of definitive documentation. For further information regarding the proposed acquisition, readers are encouraged to review the Company’s news release of May 19, 2020.

Conference replay

Canada/USA TF: 1-800-319-6413
International Toll: +1-604-638-9010
Replay Access Code: 4620

About Mota Ventures Corp.

Mota is an established eCommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature’s Exclusive brands. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President & CEO at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Tags: , , , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Mota Ventures $MOTA.ca Talks Strategy on Mushrooms and CBD $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

INTERVIEW: Datametrex $DM.ca Sells 10,000 COVID-19 Test Kits In $500,000 Deal With Global Mining Company

Posted by AGORACOM-JC at 9:16 AM on Thursday, May 21st, 2020

When US Government Agencies call you in the middle of the greatest health and economic crisis in 100 years to help them detect social media disinformation about COVID-19, it is safe to assume your Artificial Intelligence capabilities to detect fake news, disinformation campaigns and their impact is amongst the most respected in the world.

Then, when the Canadian government calls on you to help with the import and sale of COVID-19 test kits from South Korea, it is also safe to assume your trust and security clearances are at the highest levels possible.

But the real credibility payoff comes when a global mining giant, with 4,000 employees across the world, knocks on your door to buy 10,000 kits for the purposes of protecting both their employees and their families in order to get operations re-started.

You would probably also assume such a company to be a tech giant or a Silicon Valley funded startup. But Datametrex AI (DM: TSXV) is neither. Rather, it is a great Canadian small cap technology company who is giving small cap investors an opportunity to participate in the emerging world of Artificial Intelligence, as well as, the brand new world of COVID-19 testing.

When a small cap Artificial Intelligence company is successfully deploying its technology with military and conglomerates, as well as, being called upon by the Canadian federal government and global conglomerates to ask for help with the greatest pandemic in 100 years, smart small cap investors are compelled to take a closer look.

That look can begin with our latest interview of Datametrex CEO, Marshall Gunter, who discusses how the Company was able to secure its first order of 10,000 COVID-19 test kits for $500,000.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: , , , ,
Posted in AGORACOM Via Satellite, Datametrex AI Limited, Featured | Comments Off on INTERVIEW: Datametrex $DM.ca Sells 10,000 COVID-19 Test Kits In $500,000 Deal With Global Mining Company

Datametrex $DM.ca Enters Strategic Agreement to Help Provide for Processing of COVID-19 Tests for Canadian Companies

Posted by AGORACOM-JC at 9:09 AM on Thursday, May 21st, 2020
  • Signed a Strategic Partnership and Development Agreement with Transpharm Canada Inc.
  • Under the term of the Agreement TCI will work with Datametrex on scoping out services and providing access to its 25,000 sq. ft state-of-the-art testing facility located in Toronto, ON, to provide support and testing services for COVID-19 testing kits that Datametrex has in its portfolio
  • Datametrex will be providing the COVID-19 test kits. TCI will be providing all other services including but not limited to the collection of specimens, transport of specimens, and processing test results.

TORONTO, May 21, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that is has signed a Strategic Partnership and Development Agreement (the “Agreement”) with Transpharm Canada Inc. (“TCI”).

Under the term of the Agreement TCI will work with Datametrex on scoping out services and providing access to its 25,000 sq. ft state-of-the-art testing facility located in Toronto, ON, to provide support and testing services for COVID-19 testing kits that Datametrex has in its portfolio. Datametrex will be providing the COVID-19 test kits. TCI will be providing all other services including but not limited to the collection of specimens, transport of specimens, and processing test results.

TCI will design, engineer, and develop a fully integrated suite of testing systems that will include in the field and lab testing protocols using TCI’s fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility. TCI lab has a current capacity to process 2,304 nucleic acid COVID-19 real-time detection kits (the “Kits”) every 24 hrs using CFX96 real-time PCR detection system machines and is scalable to over 10,000 test kits every 24 hrs.

Transpharm will develop a Point of Care Diagnostic Kit System (the “TCI System”) with clear protocols of specimen collection, specimen handling, and specimen container labeling including the patient’s full name, date of collection, and one other unique identifier such as date of birth or government issued health card number. Transpharm will also develop a procedure focused around delivery related to specimen transport media tube protocols including to ensure cap on tube is tightly sealed, shipped at 2-8°C, 26-46°F to the TCI laboratory testing facility.

Datametrex is committed to helping Canada and Canadians find a safe and secure way to get people out of lockdown and back to work. The Company first identified the need for high quality test kits back in April, since then, it has established relationships with four South Korean manufacturers of nucleic acid test kits. The Company quickly identified that both public and private corporations are not fully equipped to administer and process the test kits on their own. As a result, the Company quickly sourced a qualified lab testing company to partner with that will provide customers with a turnkey solution to administer tests efficiently, safely, and accurately. The Company believes testing is going to be key to re-opening the economy in a safe fashion, and also believes in providing Canadians with the best solution. 

“By participating in this project, Datametrex reaffirms its commitment to helping it customers, shareholders, families, and the Canadian public. This project hopes to aid in the reopening of businesses, travel, places of worship, community spaces, and social and cultural events in a safe and economic way,” said Marshall Gunter, CEO of Datametrex.

Dr. Alexander MacGregor, founder and President of TCI, stated, “Transpharm is pleased to join in the COVID-19 fight with Datametrex and provide a world class testing facility for this endeavour. This world pandemic poses an unprecedented threat to the way that most people live their daily lives. There are several obvious steps we can take to ensure that no one must choose between their health and leaving their homes, and that begins with testing. Transpharm has the people, the equipment, and world class lab space to meet the enormous demand coming and to get the job done.”

About Transpharm Canada Inc

Transpharm Canada Inc. provides pharmaceutical education, technology, and research opportunities to students through its subsidiary, Toronto Institute of Pharmaceutical Technology, North America’s premier pharmaceutical training institute. The facility is also fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies.  Additional information on TIPT is available at www.tipt.com

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , ,
Posted in Datametrex AI Limited | Comments Off on Datametrex $DM.ca Enters Strategic Agreement to Help Provide for Processing of COVID-19 Tests for Canadian Companies

New Age Metals $NAM.ca Appoints Mr. Cody Hunt as VP Business Development $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN #PGM

Posted by AGORACOM-JC at 8:39 AM on Thursday, May 21st, 2020

May 21st, 2020 – Vancouver, Canada – New Age Metals Inc. (TSXV:NAM); (OTC:NMTLF); (FSE:P7J). The Company is pleased to appoint Mr. Cody Hunt as Vice President of Business Development.

Chairman and CEO Harry Barr stated; “Over the past two years, Mr. Hunt has done an excellent job working in all aspects of business development for New Age Metals. The board and management of New Age Metals are pleased to promote Mr. Hunt to an officer of the Company with his title of Vice President of Business Development. Going forward, Mr. Hunt will work with the board and management to find new strategic partners for the Company’s projects, participate in and monitor the technical development of our existing projects, evaluate potential new opportunities and continue to source additional funding for the Company.”

Mr. Hunt has worked for New Age since 2018 in Business Development and has been actively involved in identifying, establishing and developing strategic relationships and has participated in the development and execution of the company’s business planning and strategy. Mr. Hunt is a graduate of Queen’s University from the Robert M. Buchan Department of Mining. He received his Bachelors degree in Mining Engineering while specializing in Mineral Processing in 2018. Mr. Hunt is also actively pursuing his Chartered Financial Analyst designation.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America. The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 kilometers from Sudbury, Ontario as well as the Genesis PGM Project in Alaska. The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. New Age Metals is a junior resource company on the TSX Venture Exchange, trading symbol NAM, OTCQB:NMTLF; FSE:P7J with 137,347,966 shares issued to date.

Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at [email protected] or Cody Hunt at [email protected] or call 613 659 2773.

Opt-in List

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news.

On behalf of the Board of Directors

“Harry Barr”

Harry G. Barr

Chairman and CEO

Tags: , , , ,
Posted in New Age Metals | Comments Off on New Age Metals $NAM.ca Appoints Mr. Cody Hunt as VP Business Development $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN #PGM

CLIENT FEATURE: Eyecarrot Innovations $EYC.ca Creating Faster Brains Through Stronger Eyes $EYPT $KALA

Posted by AGORACOM-JC at 6:11 PM on Wednesday, May 20th, 2020
http://www.smallcapepicenter.com/eyc%20square.png

(TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR)

Trusted and used by some of the world’s top professional sports teams, including:

  • Eyecarrot Has Already Started Commercializing Its Vision Therapy Platform
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
    • Shipped Over 400 Binovi Units (April 2020)
    • Goal Is 2,500 Binovi Units (End Of 2020)
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Closed Major Financing In Q1 2020
  • Eyecarrot is now well positioned to further commercialize and capitalize on massive demand for Vision Therapy and Training For Athletes and Education

THE MARKET OPPORTUNITY

  • Vision Therapy captures 3% of a $36B Yearly Vision Market today
  • Vision Therapy will grow by 22% this year and account for 4% of the $39B Yearly Market by year end
  • Sights are set on disrupting the sports performance industry in 2020 while receiving engagement from leaders within the human performance – sport performance industry
  • The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014
  • Expected to grow at a CAGR of 5.9% to nearly $614.1B by 2022

AS FEATURED ON BTV:

Eyecarrot Innovations is an advertising client of AGORA Internet Relations Corp.

Tags: , , , ,
Posted in AGORACOM Client Feature, Eyecarrot Innovations Corp | Comments Off on CLIENT FEATURE: Eyecarrot Innovations $EYC.ca Creating Faster Brains Through Stronger Eyes $EYPT $KALA

Baby food sector is neglecting infants’ nutritional needs, says start-up – SPONSOR: Else Nutrition $BABY.ca $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 12:40 PM on Wednesday, May 20th, 2020

SPONSOR: Else Nutrition Holdings Inc. (TSX-V: BABY)The award winning, plant-based nutrition company for small cap investors. The company has a $10,000,000 cash balance for US product launch In Q2 2020 with International agreements in Q3. Learn More

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Baby food sector is neglecting infants’ nutritional needs, says start-up

By Oliver Morrison

UK baby foods are compromising infants’ health with excessive amount of sugar, according to Little Tummy – a start-up that hopes to disrupt the UK baby food sector with meals that it claims contains half the amount of fruit of sugar compared to many other brands.

Read More: https://www.foodnavigator.com/Article/2020/05/19/Baby-food-sector-is-neglecting-infants-nutritional-needs-says-start-up

Tags: , , , , , ,
Posted in All Recent Posts, Else Nutrition Holdings Inc. | Comments Off on Baby food sector is neglecting infants’ nutritional needs, says start-up – SPONSOR: Else Nutrition $BABY.ca $MAT $KMB $BMY $ABT $WYE

« Older Entries
Newer Entries »